Similarly, in CRC and other malignancies, the E3 ubiquitin ligase FBXO11 mediates ubiquitination and proteasomal degradation of CIITA—the master transcription factor driving MHC class II expression—leading to reduced MHC-II levels and impaired CD4+ T cell activation [102]. Here, CD4 is linked to colorectal carcinoma.